FDA Inspection 1248645 — Padagis US LLC

Padagis US LLC — FEI 2127022

The FDA completed an inspection of Padagis US LLC on September 6, 2024 in Minneapolis, MN. The inspection was classified VAI (Voluntary Action Indicated — objectionable conditions were found but do not meet the threshold for regulatory action). 1 citation was issued during this inspection. Product area: Drugs.

Inspection Details

Classification
Voluntary Action Indicated (VAI) (VAI)
End Date
September 6, 2024
Fiscal Year
2024
Product Type
Drugs
Project Area
Drug Quality Assurance
Location
Minneapolis, MN (United States)

Citations

IDCFRDescription
122421 CFR 211.67(b)(6)Cleaning SOP/inspection